These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 10229839)

  • 1. Recognition of an MHC class I-restricted antigenic peptide can be modulated by para-substitution of its buried tyrosine residues in a TCR-specific manner.
    Saito NG; Chang HC; Paterson Y
    J Immunol; 1999 May; 162(10):5998-6008. PubMed ID: 10229839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations in TCR-MHC contacts subsequent to cross-recognition of class I MHC and singly substituted peptide variants.
    Ono T; DiLorenzo TP; Wang F; Kalergis AM; Nathenson SG
    J Immunol; 1998 Nov; 161(10):5454-63. PubMed ID: 9820521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single amino acid replacements in an antigenic peptide are sufficient to alter the TCR V beta repertoire of the responding CD8+ cytotoxic lymphocyte population.
    Kalergis AM; Ono T; Wang F; DiLorenzo TP; Honda S; Nathenson SG
    J Immunol; 1999 Jun; 162(12):7263-70. PubMed ID: 10358174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. V beta 5+ T cell receptors skew toward OVA+H-2Kb recognition.
    Dillon SR; Jameson SC; Fink PJ
    J Immunol; 1994 Feb; 152(4):1790-801. PubMed ID: 8120388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Point mutations in the beta chain CDR3 can alter the T cell receptor recognition pattern on an MHC class I/peptide complex over a broad interface area.
    Goyarts EC; Vegh Z; Kalergis AM; Hörig H; Papadopoulos NJ; Young AC; Thomson CT; Chang HC; Joyce S; Nathenson SG
    Mol Immunol; 1998 Jul; 35(10):593-607. PubMed ID: 9823758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding of longer peptides to the H-2Kb heterodimer is restricted to peptides extended at their C terminus: refinement of the inherent MHC class I peptide binding criteria.
    Hörig H; Young AC; Papadopoulos NJ; DiLorenzo TP; Nathenson SG
    J Immunol; 1999 Oct; 163(8):4434-41. PubMed ID: 10510385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A molecular basis for how a single TCR interfaces multiple ligands.
    Boesteanu A; Brehm M; Mylin LM; Christianson GJ; Tevethia SS; Roopenian DC; Joyce S
    J Immunol; 1998 Nov; 161(9):4719-27. PubMed ID: 9794402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural basis of Kbm8 alloreactivity. Amino acid substitutions on the beta-pleated floor of the antigen recognition site.
    Hunt HD; Pullen JK; Dick RF; Bluestone JA; Pease LR
    J Immunol; 1990 Sep; 145(5):1456-62. PubMed ID: 2384667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The mode of ligand recognition by two peptide:MHC class I-specific monoclonal antibodies.
    Messaoudi I; LeMaoult J; Nikolić-Zugić J
    J Immunol; 1999 Sep; 163(6):3286-94. PubMed ID: 10477598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Major histocompatibility complex recognition by immune receptors: differences among T cell receptor versus antibody interactions with the VSV8/H-2Kb complex.
    Witte T; Smolyar A; Spoerl R; Goyarts EC; Nathenson SG; Reinherz EL; Chang HC
    Eur J Immunol; 1997 Jan; 27(1):227-33. PubMed ID: 9022023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Viral escape at the molecular level explained by quantitative T-cell receptor/peptide/MHC interactions and the crystal structure of a peptide/MHC complex.
    Tissot AC; Ciatto C; Mittl PR; Grütter MG; Plückthun A
    J Mol Biol; 2000 Sep; 302(4):873-85. PubMed ID: 10993729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alloreactive and syngeneic CTL are comparably dependent on interaction with MHC class I alpha-helical residues.
    Hornell TM; Solheim JC; Myers NB; Gillanders WE; Balendiran GK; Hansen TH; Connolly JM
    J Immunol; 1999 Sep; 163(6):3217-25. PubMed ID: 10477590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of self peptides in the allogeneic cross-reactivity of CTLs.
    Kuzushima K; Sun R; van Bleek GM; Vegh Z; Nathenson SG
    J Immunol; 1995 Jul; 155(2):594-601. PubMed ID: 7541821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crystal structures of murine MHC Class I H-2 D(b) and K(b) molecules in complex with CTL epitopes from influenza A virus: implications for TCR repertoire selection and immunodominance.
    Meijers R; Lai CC; Yang Y; Liu JH; Zhong W; Wang JH; Reinherz EL
    J Mol Biol; 2005 Feb; 345(5):1099-110. PubMed ID: 15644207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional mapping of the orientation for TCR recognition of an H2-Kb-restricted ovalbumin peptide suggests that the beta-chain subunit can dominate the determination of peptide side chain specificity.
    Turner SJ; Jameson SC; Carbone FR
    J Immunol; 1997 Sep; 159(5):2312-7. PubMed ID: 9278320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rational optimization of tumor epitopes using in silico analysis-assisted substitution of TCR contact residues.
    Shang X; Wang L; Niu W; Meng G; Fu X; Ni B; Lin Z; Yang Z; Chen X; Wu Y
    Eur J Immunol; 2009 Aug; 39(8):2248-58. PubMed ID: 19593772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vesicular stomatitis virus antigenic octapeptide N52-59 is anchored into the groove of the H-2Kb molecule by the side chains of three amino acids and the main-chain atoms of the amino terminus.
    Shibata K; Imarai M; van Bleek GM; Joyce S; Nathenson SG
    Proc Natl Acad Sci U S A; 1992 Apr; 89(7):3135-9. PubMed ID: 1313583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural complexity of antigenic determinants for class I MHC-restricted, hapten-specific T cells. Two qualitatively differing types of H-2Kb-restricted TNP epitopes.
    Martin S; von Bonin A; Fessler C; Pflugfelder U; Weltzien HU
    J Immunol; 1993 Jul; 151(2):678-87. PubMed ID: 8335903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unexpected T-cell recognition of an altered peptide ligand is driven by reversed thermodynamics.
    Allerbring EB; Duru AD; Uchtenhagen H; Madhurantakam C; Tomek MB; Grimm S; Mazumdar PA; Friemann R; Uhlin M; Sandalova T; Nygren PÅ; Achour A
    Eur J Immunol; 2012 Nov; 42(11):2990-3000. PubMed ID: 22837158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design of agonistic altered peptides for the robust induction of CTL directed towards H-2Db in complex with the melanoma-associated epitope gp100.
    van Stipdonk MJ; Badia-Martinez D; Sluijter M; Offringa R; van Hall T; Achour A
    Cancer Res; 2009 Oct; 69(19):7784-92. PubMed ID: 19789338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.